
Celgene has entered into a new three-year partnership with British artificial intelligence and drug discovery firm Exscientia to the value …

Merck KGaA and artificial intelligence (AI) firm Iktos have entered into a partnership, the pair have announced, to leverage the …

Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …

Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …

Dr Chris Barber, CEO of not-for-profit organisation and educational charity Lhasa Limited, discusses new innovations and ideas that are set …

Key drug discovery investment trends
Pfizer and IBM Watson Health have announced a joint venture to accelerate research in immuno-oncology. Pfizer will use IBM’s Watson …

A researcher from Purdue University’s College of Veterinary Medicine has developed a novel method of repurposing drugs to act as …

Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …
Half a dozen pharma firms are contributing £14.4 million to work by Dundee University and the Medical Research Council (MRC) on …
What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …
Use of cell-based assay technology is set to grow rapidly over the next decade, helping to speed up drug discovery …